|
Summary Information: ImmunoGen Inc. Common Stock NASDAQ:IMGN |
admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: ImmunoGen is developing the next generation of antibody-drug conjugates to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, the company aims to disrupt the progression of cancer and offer its patients more good days.
__The following are links to various summary and news pages for __ImmunoGen Inc. Common Stock [ IMGN ]. __Note: Some Links might not have information for the company. |
|